首页> 外国专利> SYNTHESIS, MOLECULAR DOCKING AND ANTIDIABETICS STUDIES OF NOVEL DIHYDROPYRIMIDO 4,5-AACRIDIN-2-AMINES

SYNTHESIS, MOLECULAR DOCKING AND ANTIDIABETICS STUDIES OF NOVEL DIHYDROPYRIMIDO 4,5-AACRIDIN-2-AMINES

机译:新型[4,5-A] AC啶-2-胺的合成,分子对接和抗糖尿病研究

摘要

Synthesis, molecular docking and antidiabetic studies of novel dihydropyrimido[4,5-a]acridin-2-amines In the preceding study, a series of novel 10-chloro-4-(2-chlorophenyl)-12-phenyl-5,6-dihydropyrimido[4,5-a]acridin-2-amines, 3a-f have been synthesized. Structures of these synthesized molecules were studied by FT-IR, [U NMR, nC NMR, EI-MS and single crystal X-ray structural analysis data. An in silico molecular docking was performed on derivatives of highest in vitro activity on a-amylase and a-glucosidase. Overall data indicate that the compound 3e is a promising lead compound for the development of selective inhibition of a-amylase and a-glucosidase. The synthesized compounds were screened for their antidiabetic activity by in vitro methods.
机译:新型二氢嘧啶并[4,5-a] ac啶-2-胺的合成,分子对接和抗糖尿病研究在先前的研究中,一系列新型10-氯-4-(2-氯苯基)-12-苯基-5,6已经合成了-二氢嘧啶基[4,5-a] ac啶-2-胺,3a-f。通过FT-IR,[U NMR,nC NMR,EI-MS和单晶X射线结构分析数据研究了这些合成分子的结构。对α-淀粉酶和α-葡糖苷酶具有最高体外活性的衍生物进行计算机内分子对接。总体数据表明,化合物3e是开发选择性抑制α-淀粉酶和α-葡萄糖苷酶的有前途的先导化合物。通过体外方法筛选合成的化合物的抗糖尿病活性。

著录项

  • 公开/公告号IN2014CH00497A

    专利类型

  • 公开/公告日2016-08-31

    原文格式PDF

  • 申请/专利权人

    申请/专利号IN497/CHE/2014

  • 申请日2014-02-04

  • 分类号A01M29/18;G01N29/00;F24F1/02;F24F5/00;F24F1/00;F24F11/02;F24F3/16;

  • 国家 IN

  • 入库时间 2022-08-21 14:25:33

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号